This inventor holds 2 USPTO granted patents. Top assignee: The General Hospital Corporation. Active years: 2000-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000-2001
Title: Shobu Namura: Innovator in Ischemia Research
Introduction
Shobu Namura is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of ischemia research, particularly through his innovative use of MEK1 inhibitors. With a total of 2 patents, his work focuses on reducing tissue damage associated with ischemia and reperfusion.
Latest Patents
Namura's latest patents include the use of MEK1 inhibitors as protective agents against damage due to ischemia. This invention specifically addresses the reduction of brain damage resulting from ischemia associated with stroke. Additionally, he has developed pharmaceutical compositions, kits, and perfusion fluids that incorporate MEK1 inhibitors to enhance their protective effects.
Career Highlights
Shobu Namura is affiliated with The General Hospital Corporation, where he continues to advance his research and innovations. His work has garnered attention for its potential to improve outcomes for patients suffering from ischemic conditions.
Collaborations
Namura collaborates with esteemed colleagues, including Alessandro Alessandrini and Joseph V Bonventre, to further his research initiatives and explore new avenues in ischemia treatment.
Conclusion
Shobu Namura's contributions to ischemia research through his innovative patents highlight his commitment to advancing medical science. His work has the potential to significantly impact patient care and treatment options in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile